AAI congratulates 2026 Career Awardees for outstanding research and career achievements! Join us to honor them at IMMUNOLOGY2026™. Learn more: https://t.co/ES2PQRUKuM.
Thrilled to announce that our review on IL-22 is out!
This unique cytokine targets non-immune cells to promote gut barrier repair and fight inflammation while connecting mucosal immunity to systemic metabolism — a promising new therapeutic avenue for IBD and beyond.
A 2023 @SciImmunology Review contextualizes advances in CAR T cell #cancer immunotherapy, summarizing studies that explore the impact of metabolic stress on this treatment’s efficacy in the tumor microenvironment.
Learn more: https://t.co/gAEBKYWAsA #ScienceMagArchives
PLT012, a Humanized CD36-Blocking Antibody, Is Effective for Unleashing Anti-Tumor Immunity against Liver Cancer and Liver Metastasis - by Sheue-Fen Tzeng, Yi-Ru Yu, Chin-Hsien Tsai, @PCHo_Lab, and colleagues at @Ludwig_Cancer@unil@TaipeiMedicalU https://t.co/Egd8lKv15C
Our updated inventory of genes required for #OXPHOS & findings on #mito defects in #Menieres is now out at @CellReports! 🎉
🧫 New galactose #CRISPR screen
🎯 481 genes required for #OXPHOS
⚙️ #FAM136A in IMS proteostasis
👂 Mito defects in #Menieres
https://t.co/RM6OOK93yK
We're recruiting a postdoc to join my lab at @OxfordOncology & Centre for Immuno-Oncology, @UniofOxford to understand immune regulation in cancer and develop new approaches for cancer prevention and metastasis.
Deadline: 11 August 2025
Apply here: https://t.co/z29ZmDjdGS
Researchers led by Ludwig @unil’s Ping-Chih Ho, Xiaoyun Li & Sofie Hedlund Møller report that cancer cells secrete fats that prompt fibroblasts to flip macrophages into a pro-cancer state. Disrupting this process impairs growth in melanoma tumors in mice. https://t.co/igKmZ8hkCg
Li, Møller, Ho et al. @unil show how tumor-derived lipids can induce an IL-6–dependent increased glutamine synthesis pathway in cancer-associated fibroblasts, supporting CAFs ability to promote pro-tumorigenic tumor-associated macrophages. https://t.co/O4mHZAE1HS